| http://www.w3.org/ns/prov#value | - r 2012Deutsches Krebsforschungszentrum Stiftung Des Offentlichen RechtsTreatment of tumors using specific anti-L1 antibodyUS814783513 Aug 20093 Apr 2012Emergent Product Development Seattle, LlcMolecularly engineered binding domain-immunoglobulin fusion proteins, including single chain Fv-immunoglobulin fusion protein useful for treating malignant conditions and B-cell disorders, such as disease ca
|
